Ascendis Pharma ADR
(ASND)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | RGC | GH | ||
| Company | Ascendis Pharma ADR | Regencell Bioscience Holdings Ltd | Guardant Health Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 211.00 | 26.92 | 108.00 | ||
| High | 222.99 | 30.39 | 108.51 | ||
| Low | 211.00 | 25.85 | 100.28 | ||
| Latest | 218.10 | 29.02 | 102.76 | ||
| Change | -3.39 | +2.30 | -4.82 | ||
| % Change | -1.53% | +8.61% | -4.48% | ||
| Volume | 1,684,400 | 193,100 | 2,006,100 | ||
| 20-Day Average Volume | 761,835 | 363,100 | 2,046,895 | ||
| Previous Close | 221.49 | 26.72 | 107.58 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 222.77 | 27.99 | 110.27 | ||
| 20-Day Raw Stochastic | 42.15% | 48.32% | 22.57% | ||
| 20-Day Relative Strength | 50.24 | 52.24 | 46.35 | ||
| Weighted Alpha | +47.05 | +111.93 | +94.73 | ||
| Today's Opinion | 88% Buy | 96% Buy | 56% Buy | ||
| Previous Opinion | 88% Buy | 80% Buy | 72% Buy | ||
| Last Month's Opinion | 96% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.33% since 02/05/26 | +15.76% since 02/05/26 | +4.47% since 02/05/26 | ||
| Low | 211.00 on 02/12/26 | 25.80 on 02/11/26 | 97.52 on 02/06/26 | ||
| High | 226.40 on 02/09/26 | 30.39 on 02/12/26 | 108.51 on 02/12/26 | ||
| 1-Month | |||||
| %Chg | +4.47% since 01/12/26 | -34.21% since 01/12/26 | -4.47% since 01/12/26 | ||
| Low | 200.68 on 01/20/26 | 20.81 on 01/22/26 | 97.52 on 02/06/26 | ||
| High | 242.00 on 01/28/26 | 45.59 on 01/13/26 | 120.74 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +9.48% since 11/12/25 | +112.13% since 11/12/25 | +5.03% since 11/12/25 | ||
| Low | 188.07 on 11/13/25 | 10.33 on 11/25/25 | 90.43 on 11/14/25 | ||
| High | 242.00 on 01/28/26 | 69.00 on 01/08/26 | 120.74 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +11.29% since 08/12/25 | +115.92% since 08/12/25 | +86.50% since 08/12/25 | ||
| Low | 186.05 on 10/20/25 | 10.33 on 11/25/25 | 53.40 on 09/16/25 | ||
| High | 242.00 on 01/28/26 | 69.00 on 01/08/26 | 120.74 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,517,184 | 14,350,071 | 12,951,974 | ||
| Shares Outstanding, K | 61,977 | 494,489 | 126,041 | ||
| Annual Sales | 393,500,000 | 0 | 739,020,000 | ||
| Annual Net Income | -409,120,000 | -3,580,000 | -436,370,000 | ||
| Last Quarter Sales | 249,720,000 | N/A | 265,200,000 | ||
| Last Quarter Net Income | -71,290,000 | N/A | -92,730,000 | ||
| 60-Month Beta | 0.44 | 2.02 | 1.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.17 on 11/12/25 | N/A | -0.39 on 10/29/25 | ||
| Latest Earnings Date | 05/07/26 | 01/30/26 | 02/19/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 02/15/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||